Therapeutic outcome and side-effects after radiotherapy, chemotherapy and/or hyperthermia treatment of head and neck tumour xenografts

European Journal of Cancer

Volumn 38, Issue 4, 2002, Pages 594-601

  Ressel, A ^a   Schmitt, O ^a   Weiss, C ^a   Feyerabend, T ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Chemotherapy; Head and neck cancer; Local hyperthermia; Radiotherapy; Tumour xenograft

Indexed keywords

CISPLATIN; IFOSFAMIDE;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK TUMOR; HEMATOCRIT; HISTOPATHOLOGY; HUMAN; HYPERTHERMIA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RADIATION RESPONSE; REMISSION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME; TUMOR XENOGRAFT; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; MALE; MICE; MICE, NUDE; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 0036188131     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00411-7     Document Type: Article

References (29)

1. Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: A phase I/II study
2. Local hyperthermia, radiation, and chemotherapy in locally advanced malignancies
3. Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region
4. Thermal distributions in a water bath heated mouse tumor
5. Combined effects of hyperthermia, bleomycin, and X-rays on Ehrlich ascites tumor
6. Synergism between alkylating agent and cis-platin with moderate local hyperthermia: The effect of multidrug chemotherapy in an animal system
7. Can mild hyperthermia improve tumor oxygenation?
8. Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma
9. Clinical hyperthermia combined with drugs and radiation. A phase I/II study
10. Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck
11. Ifosfamid and mesna for the treatment of advanced squamous cell head and neck cancer
12. Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide
13. Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models
14. Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 mice
15. Eradication of a disseminated syngeneic mouse lymphoma by systemic adoptive transfer of immune lymphocytes and its dependence upon a host component(s)
16. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies
17. Rationale and clinical status of local hyperthermia, radiation, and chemotherapy in locally advanced malignancies
18. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue
19. Sequencing of trimodality therapy [cis-diammine-dichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma
20. Thermo-chemo-radiotherapy of oesophageal cancer
21. A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies
22. Response of previously irradiated skin to combinations of X-radiation, hyperthermia and cis-diamminedichloroplatinum
23. Radiation, adriamycin and skin reactions: Effects of radiation and drug fractionation, hyperthermia and tetracycline
24. Comparative pharmacokinetics of ifosfamide, 4-hydroxyifos-famide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy
25. Prediction of ifosfamide/mesna associated encephalopathy
26. Central nervous system toxicity following treatment of pediatric patients with ifosfamide/mesna
27. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: A prospective study
28. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx
29. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supra-glottic larynx